If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
2
Followers on Owler
Vivaphysicians
is a Private company. Vivaphysicians generates $14.1K in revenue per employee Vivaphysicians has 2 followers on Owler.
Overview
News & Insights
Vivaphysicians
is a Private company. Vivaphysicians generates $14.1K in revenue per employee Vivaphysicians has 2 followers on Owler.
CEO
Add
CEO Approval Rating
- -/100
2002
Jose
California
San Francisco Bay Area
Private
Non-Profit & Government
Add Sector
8300
NAICS listing
http://www.vivaphysicians.org
Est. Annual Revenue
$100K-5.0M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
News
Latest News
Aug 10, 2021
PR Newswire
Press Release: Vivaphysicians : Results from 16 Significant Vascular Interventional Clinical Trials to Be Presented for the First Time at VIVA21
Nov 07, 2020
StreetInsider
Press Release: Vivaphysicians : Final Five Unpublished Late-Breaking Clinical Trial Results Announced at VIVA20
Nov 07, 2020
Markets Insider
Vivaphysicians: Final Five Unpublished Late-Breaking Clinical Trial Results Announced at VIVA20 | Markets Insider
Sep 09, 2020
PR Newswire
Press Release: Vivaphysicians : Results from 10 Highly Anticipated Vascular Interventional Clinical Trials to Be Presented for the First Time at VIVA20
Jun 21, 2020
Acrofan
Vivaphysicians: VIVA Late-Breaking Clinical Trial Session to Showcase TOBA II BTK One-Year Data
May 11, 2020
PR Newswire
Press Release: Vivaphysicians : VIVA Physicians Publishes Analysis Evaluating Mortality and Paclitaxel-Coated Devices
Nov 06, 2019
MarketScreener
Vivaphysicians: VIVA Presentation Supports Zilver� PTX� Benefits Across Different Patient Groups
Nov 06, 2019
PR Newswire
Press Release: Vivaphysicians : New Unpublished Clinical Trial Results Announced at VIVA19
Sep 16, 2019
StreetInsider
Press Release: Vivaphysicians : Results From 20 Highly Anticipated Vascular Interventional Clinical Trials to Be Presented for the First Time at VIVA19
Mar 09, 2019
PR Newswire
Press Release: Vivaphysicians : VIVA Physicians Selects NAMSA as Statistical Analytic Group to Evaluate the Safety of Paclitaxel Drug-Eluting Technologies in PAD
Follow and Get Alerts
Trending Companies